More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-06-10-08-16-03-801-6a291d439e32b2e06b43079b.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-06-10-08-05-12-423-6a291ab8db6e3a10f1e46bd6.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-06-11-09-39-52-448-6a2a82687c79c34c14d99648.jpg)